Conatus Pharmaceuticals, Inc.. (CNAT) NASDAQ

$0.56 - (-)

Market Cap: $18.58M

As of 05/26/20 04:00 PM EDT. Market closed.

(CNAT)

Conatus Pharmaceuticals, Inc.. (CNAT)
NASDAQ

$0.56
- (-)

Market Cap: $18.58M

As of 05/26/20 04:00 PM EDT. Market closed.

Add to Portfolio

Conatus Pharmaceuticals, Inc. is a biotechnology company that focuses on the development and commercialization of novel medicines to treat chronic diseases. The firm engages in developing emricasan, an orally active pan-caspase inhibitor, for the treatment of patients with chronic liver disease and is designed to reduce the activities of human caspases. It also develops CTS-2090, an orally active ... read more

Conatus Pharmaceuticals, Inc. is a biotechnology company that focuses on the development and commercialization of novel medicines to treat chronic diseases. The firm engages in developing emricasan, an orally active pan-caspase inhibitor, for the treatment of patients with chronic liver disease and is designed to reduce the activities of human caspases. It also develops CTS-2090, an orally active selective caspase inhibitor, for diseases involving inflammasome pathways. The company was founded by Alfred P. Spada, Jennifer Giottonini Cayer, and Steven J. Mento on July 13, 2005 and is headquartered in San Diego, CA. read less

COMPANY PROFILE
Sector
Health Technology
Industry
Biotechnology
CEO
Steven J. Mento
Full Time Employees
6
CEO Compensation (Base)
$521,433
CEO Compensation (Total)
$1.30M
URL
Address
16745 West Bernardo Drive, CA, San Diego, 92127-7619.
Sector
Health Technology
Industry
Biotechnology
CEO
Steven J. Mento
Full Time Employees
6
CEO Compensation (Base)
$521,433
CEO Compensation (Total)
$1.30M
Address
16745 West Bernardo Drive, CA, San Diego, 92127-7619.
PRICE CHART FOR CONATUS PHARMACEUTICALS, INC.
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
-
Days Range
- - -
52 week range
$0.23 - $1.07
Volume
0
Avg. Volume (30 days)
2,531,496
Market Cap
$18.58M
Dividend Yield
-
P/E
-
Shares Outstanding
33,170,000
Open
-
Previous Close
-
Days Range
- - -
52 week range
$0.23 - $1.07
Volume
0
Avg. Volume (30 days)
2,531,496
Market Cap
$18.58M
Dividend Yield
-
P/E
-
Shares Outstanding
33,170,000
FINANCIAL STATEMENTS FOR CONATUS PHARMACEUTICALS, INC.
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR CONATUS PHARMACEUTICALS, INC.
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Pascoe Richard WPresident, CEO & DirectorMar 30, 2021 Buy$1.1420,00022,80030,000Mar 30, 2021, 06:28 PM
Pascoe Richard WPresident, CEO & DirectorDec 03, 2020 Buy$1.2410,00012,39410,000Dec 07, 2020, 04:06 PM
Marshall Keith WEVP, COO & CFOMay 22, 2020 Option Exercise$0.5618,61510,42419,885May 27, 2020, 06:09 AM
Spada Alfred P.EVP, R&D and CSOMay 22, 2020 Option Exercise$0.5612,9607,25819,595May 27, 2020, 06:05 AM
Mento Steven JDirectorMay 22, 2020 Option Exercise$0.5631,42817,60039,572May 27, 2020, 06:04 AM
Smith Edward F IIISVP, Reg Affairs and QAMay 14, 2018 Option Exercise$3.314,69015,5249,151Feb 11, 2019, 04:20 PM
Smith Edward F IIISVP, Reg Affairs and QANov 14, 2018 Option Exercise$3.151,7245,43110,875Feb 11, 2019, 04:20 PM
RIPLEY DANIEL L.SVP, Bus Dev, P&A MgmtNov 14, 2018 Option Exercise$3.151,8615,86232,431Feb 11, 2019, 04:19 PM
RIPLEY DANIEL L.SVP, Bus Dev, P&A MgmtMay 14, 2018 Option Exercise$3.311,2904,27030,570Feb 11, 2019, 04:19 PM
Mento Steven JPresident, CEO & DirectorMay 04, 2018 Option Exercise$0.9960,00059,40060,000May 07, 2018, 07:46 PM
Spada Alfred P.EVP, R&D and CSOFeb 27, 2018 Option Exercise$1.2412,12115,03012,121Mar 01, 2018, 04:08 PM
Smith Edward F IIISVP, Reg Affairs and QANov 14, 2017 Option Exercise$3.484,46115,5244,461Feb 05, 2018, 05:03 PM
RIPLEY DANIEL L.SVP, Bus Dev, P&A MgmtNov 14, 2017 Option Exercise$3.488182,84729,280Feb 05, 2018, 05:02 PM
RIPLEY DANIEL L.SVP, Bus Dev, P&A MgmtMay 12, 2017 Option Exercise$1.707611,29428,462Feb 05, 2018, 05:02 PM
Cashion CharlesSVP, Finance, CFO and Sec.Jan 09, 2017 Option Exercise$0.9942,42442,00042,424Jan 11, 2017, 04:01 PM
Mento Steven JPresident, CEO & DirectorDec 20, 2016 Option Exercise$1.2141,41450,09141,414Dec 22, 2016, 04:04 PM
Van Wart HaroldDirectorOct 27, 2016 Option Exercise$0.2518,1814,54518,181Oct 31, 2016, 04:37 PM
KISNER DANIEL LDirectorApr 08, 2015 Buy$5.754,00023,0007,145Apr 10, 2015, 04:02 PM
HALE DAVID FDirectorJan 08, 2014 Option Exercise$0.9912,12112,00024,242Jan 10, 2014, 05:07 PM
HALE DAVID FDirectorSep 26, 2013 Option Exercise$2.3112,12128,00012,121Sep 27, 2013, 04:29 PM
Aberdare GP III, L.L.C.10% OwnerJul 30, 2013 Option Exercise$11.002512,76149,949Aug 01, 2013, 07:18 PM
Aberdare GP III, L.L.C.10% OwnerJul 30, 2013 Option Exercise$11.0010,614116,7542,121,992Aug 01, 2013, 07:18 PM
Aberdare GP III, L.L.C.10% OwnerJul 30, 2013 Buy$11.002,47027,17052,419Aug 01, 2013, 07:18 PM
Aberdare GP III, L.L.C.10% OwnerJul 30, 2013 Buy$11.00104,9521,154,4722,226,944Aug 01, 2013, 07:18 PM
Aberdare GP III, L.L.C.10% OwnerJul 30, 2013 Sale$11.001415449,698Aug 01, 2013, 07:18 PM
Aberdare GP III, L.L.C.10% OwnerJul 30, 2013 Sale$11.005526,0722,111,378Aug 01, 2013, 07:18 PM
Aberdare GP III, L.L.C.10% OwnerJul 30, 2013 Option Exercise$0.0873,3956,0552,111,930Aug 01, 2013, 07:18 PM
Aberdare GP III, L.L.C.10% OwnerJul 30, 2013 Option Exercise$0.081,72714249,712Aug 01, 2013, 07:18 PM
Perret Marc OlivierDirectorJul 30, 2013 Option Exercise$11.0016,742184,1621,321,795Aug 01, 2013, 07:18 PM
Perret Marc OlivierDirectorJul 30, 2013 Buy$11.00165,5251,820,7751,487,320Aug 01, 2013, 07:18 PM
Perret Marc OlivierDirectorJul 30, 2013 Sale$11.003523,8721,305,053Aug 01, 2013, 07:18 PM
Mento Steven JPresident, CEO & DirectorJul 30, 2013 Option Exercise$11.001,39515,345371,869Aug 01, 2013, 07:16 PM
Mento Steven JPresident, CEO & DirectorJul 30, 2013 Buy$11.0013,800151,800385,669Aug 01, 2013, 07:16 PM
KLINGENSTEIN PAUL HDirectorJul 30, 2013 Option Exercise$11.0010,614116,7542,121,992Aug 01, 2013, 07:16 PM
KLINGENSTEIN PAUL HDirectorJul 30, 2013 Option Exercise$11.002512,76149,949Aug 01, 2013, 07:16 PM
KLINGENSTEIN PAUL HDirectorJul 30, 2013 Buy$11.00104,9521,154,4722,226,944Aug 01, 2013, 07:16 PM
KLINGENSTEIN PAUL HDirectorJul 30, 2013 Buy$11.002,47027,17052,419Aug 01, 2013, 07:16 PM
KLINGENSTEIN PAUL HDirectorJul 30, 2013 Sale$11.001415449,698Aug 01, 2013, 07:16 PM
KLINGENSTEIN PAUL HDirectorJul 30, 2013 Sale$11.005526,0722,111,378Aug 01, 2013, 07:16 PM
KLINGENSTEIN PAUL HDirectorJul 30, 2013 Option Exercise$0.081,72714249,712Aug 01, 2013, 07:16 PM
KLINGENSTEIN PAUL HDirectorJul 30, 2013 Option Exercise$0.0873,3956,0552,111,930Aug 01, 2013, 07:16 PM
Malik ShahzadDirectorJul 30, 2013 Option Exercise$11.0019,223211,4531,976,782Aug 01, 2013, 07:14 PM
Malik ShahzadDirectorJul 30, 2013 Buy$11.00190,0542,090,5942,166,836Aug 01, 2013, 07:14 PM
Malik ShahzadDirectorJul 30, 2013 Sale$11.005355,8851,957,559Aug 01, 2013, 07:14 PM
Malik ShahzadDirectorJul 30, 2013 Option Exercise$0.0870,0035,7751,958,094Aug 01, 2013, 07:14 PM
LACASSE LOUIS PDirectorJul 30, 2013 Option Exercise$11.0012,537137,907685,937Aug 01, 2013, 07:12 PM
LACASSE LOUIS PDirectorJul 30, 2013 Buy$11.00123,9501,363,450809,887Aug 01, 2013, 07:12 PM
HALE DAVID FDirectorJul 30, 2013 Option Exercise$11.002612,871141,151Aug 01, 2013, 07:11 PM
HALE DAVID FDirectorJul 30, 2013 Buy$11.002,58828,468143,739Aug 01, 2013, 07:11 PM
COOPERATIVE GILDE HEALTHCARE II U.A.10% OwnerJul 30, 2013 Option Exercise$11.0016,742184,1621,321,795Aug 01, 2013, 07:10 PM
COOPERATIVE GILDE HEALTHCARE II U.A.10% OwnerJul 30, 2013 Buy$11.00165,5251,820,7751,487,320Aug 01, 2013, 07:10 PM
COOPERATIVE GILDE HEALTHCARE II U.A.10% OwnerJul 30, 2013 Sale$11.003523,8721,305,053Aug 01, 2013, 07:10 PM
ADVENT VENTURE PARTNERS LLP10% OwnerJul 30, 2013 Option Exercise$11.0019,223211,4531,976,782Aug 01, 2013, 07:09 PM
ADVENT VENTURE PARTNERS LLP10% OwnerJul 30, 2013 Buy$11.00190,0542,090,5942,166,836Aug 01, 2013, 07:09 PM
ADVENT VENTURE PARTNERS LLP10% OwnerJul 30, 2013 Sale$11.005355,8851,957,559Aug 01, 2013, 07:09 PM
ADVENT VENTURE PARTNERS LLP10% OwnerJul 30, 2013 Option Exercise$0.0870,0035,7751,958,094Aug 01, 2013, 07:09 PM
Scopa James PaulDirectorJul 30, 2013 Option Exercise$11.0016,716183,8761,026,815Aug 01, 2013, 02:21 PM
Scopa James PaulDirectorJul 30, 2013 Buy$11.00165,2651,817,9151,192,080Aug 01, 2013, 02:21 PM
EVNIN LUKE10% OwnerJul 30, 2013 Option Exercise$11.0016,716183,8761,026,815Aug 01, 2013, 02:19 PM
EVNIN LUKE10% OwnerJul 30, 2013 Buy$11.00165,2651,817,9151,192,080Aug 01, 2013, 02:19 PM
MPM BioVentures IV QP LP10% OwnerJul 30, 2013 Option Exercise$11.0016,716183,8761,026,815Aug 01, 2013, 02:18 PM
MPM BioVentures IV QP LP10% OwnerJul 30, 2013 Buy$11.00165,2651,817,9151,192,080Aug 01, 2013, 02:18 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Pascoe Richard WPresident, CEO & Director03/30/202122,800
Pascoe Richard WPresident, CEO & Director12/03/202012,394
Marshall Keith WEVP, COO & CFO05/22/202010,424
Spada Alfred P.EVP, R&D and CSO05/22/20207,258
Mento Steven JDirector05/22/202017,600
Smith Edward F IIISVP, Reg Affairs and QA05/14/201815,524
Smith Edward F IIISVP, Reg Affairs and QA11/14/20185,431
RIPLEY DANIEL L.SVP, Bus Dev, P&A Mgmt11/14/20185,862
RIPLEY DANIEL L.SVP, Bus Dev, P&A Mgmt05/14/20184,270
Mento Steven JPresident, CEO & Director05/04/201859,400
Spada Alfred P.EVP, R&D and CSO02/27/201815,030
Smith Edward F IIISVP, Reg Affairs and QA11/14/201715,524
RIPLEY DANIEL L.SVP, Bus Dev, P&A Mgmt11/14/20172,847
RIPLEY DANIEL L.SVP, Bus Dev, P&A Mgmt05/12/20171,294
Cashion CharlesSVP, Finance, CFO and Sec.01/09/201742,000
Mento Steven JPresident, CEO & Director12/20/201650,091
Van Wart HaroldDirector10/27/20164,545
KISNER DANIEL LDirector04/08/201523,000
HALE DAVID FDirector01/08/201412,000
HALE DAVID FDirector09/26/201328,000
Aberdare GP III, L.L.C.10% Owner07/30/20132,761
Aberdare GP III, L.L.C.10% Owner07/30/2013116,754
Aberdare GP III, L.L.C.10% Owner07/30/201327,170
Aberdare GP III, L.L.C.10% Owner07/30/20131,154,472
Aberdare GP III, L.L.C.10% Owner07/30/2013154
Aberdare GP III, L.L.C.10% Owner07/30/20136,072
Aberdare GP III, L.L.C.10% Owner07/30/20136,055
Aberdare GP III, L.L.C.10% Owner07/30/2013142
Perret Marc OlivierDirector07/30/2013184,162
Perret Marc OlivierDirector07/30/20131,820,775
Perret Marc OlivierDirector07/30/20133,872
Mento Steven JPresident, CEO & Director07/30/201315,345
Mento Steven JPresident, CEO & Director07/30/2013151,800
KLINGENSTEIN PAUL HDirector07/30/2013116,754
KLINGENSTEIN PAUL HDirector07/30/20132,761
KLINGENSTEIN PAUL HDirector07/30/20131,154,472
KLINGENSTEIN PAUL HDirector07/30/201327,170
KLINGENSTEIN PAUL HDirector07/30/2013154
KLINGENSTEIN PAUL HDirector07/30/20136,072
KLINGENSTEIN PAUL HDirector07/30/2013142
KLINGENSTEIN PAUL HDirector07/30/20136,055
Malik ShahzadDirector07/30/2013211,453
Malik ShahzadDirector07/30/20132,090,594
Malik ShahzadDirector07/30/20135,885
Malik ShahzadDirector07/30/20135,775
LACASSE LOUIS PDirector07/30/2013137,907
LACASSE LOUIS PDirector07/30/20131,363,450
HALE DAVID FDirector07/30/20132,871
HALE DAVID FDirector07/30/201328,468
COOPERATIVE GILDE HEALTHCARE II U.A.10% Owner07/30/2013184,162
COOPERATIVE GILDE HEALTHCARE II U.A.10% Owner07/30/20131,820,775
COOPERATIVE GILDE HEALTHCARE II U.A.10% Owner07/30/20133,872
ADVENT VENTURE PARTNERS LLP10% Owner07/30/2013211,453
ADVENT VENTURE PARTNERS LLP10% Owner07/30/20132,090,594
ADVENT VENTURE PARTNERS LLP10% Owner07/30/20135,885
ADVENT VENTURE PARTNERS LLP10% Owner07/30/20135,775
Scopa James PaulDirector07/30/2013183,876
Scopa James PaulDirector07/30/20131,817,915
EVNIN LUKE10% Owner07/30/2013183,876
EVNIN LUKE10% Owner07/30/20131,817,915
MPM BioVentures IV QP LP10% Owner07/30/2013183,876
MPM BioVentures IV QP LP10% Owner07/30/20131,817,915
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR CONATUS PHARMACEUTICALS, INC.
LOADING...